The timing and agenda for each webinar is as follows:
- Case-Based Discussion
- Managing virologic failure in a heavily treatment–experienced patient
- Switching ART in a virologically suppressed patient with underlying resistance and significant drug–drug interactions
- Question and Answer Session
Rodrigo Burgos, PharmD, MPH
Clinical Assistant Professor
Department of Pharmacy Practice
College of Pharmacy
Suzanne Molino, PharmD, BCPS, AAHIVP
Arnold & Marie Schwartz College of Pharmacy & Health Sciences
Long Island University
Clinical Pharmacy Specialist
Special Treatment and Research (STAR) Health Center
One Brooklyn Health
Brooklyn, New York
Integrate best practices in the evidence-based management of ART across the spectrum of ART experience.
This program is intended for pharmacists, and other healthcare professionals who provide care for patients with HIV infection.
Upon completion of this activity, participants should be able to:
- Integrate best practices in the evidence-based management of ART across the spectrum of ART experience
- Incorporate the latest data and expert insights on emerging innovative ARV treatment or prevention paradigms into the individualized care of persons with or at risk of HIV infection
- Appropriately counsel patients regarding the anticipated clinical role of new and investigational ART regimens
ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-22-200-L02-P has been assigned to this live application-based activity (initial release date 8/23/2022). This activity is approved for 1.0 contact hour (0.1 CEUs) in states that recognize ACPE providers. The activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.clinicaloptions.com, and proof of completion will be posted in NABP CPE Monitor profiles.
ProCE, LLC and Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE and CCO policy. ProCE and CCO are committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. Faculty disclosures will be provided prior to the start of the CE activity.